Kameron B Rodrigues
Overview
Explore the profile of Kameron B Rodrigues including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
84
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodrigues K, Weng Z, Graham Z, Lavin K, McAdam J, Tuggle S, et al.
Proc Natl Acad Sci U S A
. 2025 Jan;
122(3):e2406954122.
PMID: 39805013
Exercising regularly promotes health, but these benefits are complicated by acute inflammation induced by exercise. A potential source of inflammation is cell-free DNA (cfDNA), yet the cellular origins, molecular causes,...
2.
Rauch P, Gopakumar J, Silver A, Nachun D, Ahmad H, McConkey M, et al.
Nat Cardiovasc Res
. 2024 Aug;
2(9):805-818.
PMID: 39196062
Clonal hematopoiesis of indeterminate potential (CHIP) is defined by the presence of a cancer-associated somatic mutation in white blood cells in the absence of overt hematological malignancy. It arises most...
3.
DeGorter M, Goddard P, Karakoc E, Kundu S, Yan S, Nachun D, et al.
bioRxiv
. 2023 Nov;
PMID: 37986808
Mapping the functional human genome and impact of genetic variants is often limited to European-descendent population samples. To aid in overcoming this limitation, we measured gene expression using RNA sequencing...
4.
Rodrigues K, Dufort M, Llibre A, Speake C, Rahman M, Bondet V, et al.
Diabetologia
. 2020 Jun;
63(8):1576-1587.
PMID: 32500289
Aims/hypothesis: Self-antigen-specific T cell responses drive type 1 diabetes pathogenesis, but alterations in innate immune responses are also critical and not as well understood. Innate immunity in human type 1...
5.
Rahman M, Rodrigues K, Quiel J, Liu Y, Bhargava V, Zhao Y, et al.
JCI Insight
. 2018 Feb;
3(3).
PMID: 29415894
Type I IFN (IFN-I) dysregulation contributes to type 1 diabetes (T1D) development, and although increased IFN-I signals are pathogenic at the initiation of autoimmune diabetes, IFN-I dysregulation at later pathogenic...
6.
Havas A, Rodrigues K, Bhakta A, Demirjian J, Hahn S, Tran J, et al.
Cancer Biol Ther
. 2016 Oct;
17(12):1240-1252.
PMID: 27791595
Diffuse Large B-cell lymphoma (DLBCL) is an aggressive malignancy that has a 60 percent 5-year survival rate, highlighting a need for new therapeutic approaches. Histone deacetylase inhibitors (HDACi) are novel...
7.
Cataisson C, Michalowski A, Shibuya K, Ryscavage A, Klosterman M, Wright L, et al.
Sci Signal
. 2016 Jun;
9(433):ra62.
PMID: 27330189
The receptor tyrosine kinase MET is abundant in many human squamous cell carcinomas (SCCs), but its functional significance in tumorigenesis is not clear. We found that the incidence of carcinogen-induced...
8.
Rahman M, Rahir G, Dong M, Zhao Y, Rodrigues K, Hotta-Iwamura C, et al.
J Immunol
. 2016 Jan;
196(5):2031-40.
PMID: 26826238
Innate immune signals help break self-tolerance to initiate autoimmune diseases such as type 1 diabetes, but innate contributions to subsequent regulation of disease progression are less clear. Most studies have...